LISLE, Ill.--(BUSINESS WIRE)--Molex will showcase next-generation MedTech solutions and manufacturing capabilities from booth 3278 at the MD&M West 2020 Exhibition, February 11–13, 2020 at the Anaheim Convention Center. Molex has led the way in the convergence of electronic product integration into medical applications in order to serve the healthcare ecosystem. The company employs a collaborative approach with customers to develop cutting-edge solutions to the medical industry's most challenging problems in three core areas: diagnostic, therapeutic and monitoring.
Built on decades of expertise, Molex steadily expanded its role within the medical industry via research and development, as well as strategic acquisitions including Affinity Medical Technologies, FCT Electronics Group, Phillips-Medisize, Polymicro Technologies, ProTek Medical, Soligie, Inc., and Temp-Flex Specialty Wire and Cable. Today, Molex offers a broad portfolio of innovative, reliable and highly customizable solutions to meet the evolving needs of the medical electronics industry. For example, Molex MedTech solutions can be integrated into groundbreaking surgical equipment, wearables for diagnostic and monitoring, and implantable pharmaceutical medication delivery devices.
“In this exciting age of digitalization and connected health, it’s imperative to have customizable solutions that seamlessly integrate into medical devices and equipment. This helps ensure high-quality and reliable delivery of the best patient care, while streamlining costs for development, prototyping and manufacturing,” said Anthony Kalaijakis, strategic medical marketing manager, Molex.
As the demand for diagnostic solutions is predicted to climb, Molex’s integrated technologies are designed to serve the need for access to immediate imaging data by enabling clear communication, from the point of data capture to receipt – even on the road. The company’s solutions are well-suited to support MRI, ultrasound and general x-ray applications, as well as even more complex in vitro diagnostic testing.
Therapeutic solutions are also rapidly evolving, as the popularity of minimally invasive robotic surgery and implantable medical devices (such as defibrillators) continues to grow. The need for technology that combines power, portability, miniaturization and digital bandwidth has never been greater. Molex solutions answer the call for critical and even life-saving technology for interventional, cardiology and audiology therapeutic areas.
Lastly, remote monitoring of healthcare consumers is on the rise as the cost of inpatient medical care continues to escalate. Molex addresses the need for smaller, lighter weight and highly portable monitoring and telehealth solutions across cardiac care (ECG), diabetes management (glucose monitoring/delivery) and vital signs, to help providers keep readmissions down and offer patients home-based convenience, better quality of life and anytime/anywhere connectivity with their clinicians.
Molex continues to leverage its proven technologies in new innovations that advance precision medicine, combination therapies and monitoring of the entire wireless body area network. “The right solution provider and medical device design can minimize risk and design complexity, while achieving launch timelines and compliance with medical device regulations. We’re excited to showcase our latest innovations at MDM West as Molex helps to accelerate the future vision of patient care,” added Kalaijakis.
For more information about Molex MedTech solutions, stop by booth 3278 at MD&M West and visit www.molex.com.
About Molex:
Molex brings together innovation and technology to deliver electronic solutions to customers worldwide. With a presence in more than 40 countries, Molex offers a full suite of solutions and services for many markets, including data communications, consumer electronics, automotive, medical, and industrial. For more information, please visit www.molex.com.
Molex is a registered trademark of Molex, LLC in the United States of America and may be registered in other countries; all other trademarks listed herein belong to their respective owners.
